UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 192

Sortiert nach

Staphylococcus aureus and Sézary syndrome

Blood, 2024-04, Vol.143 (15), p.1436

Merlio, Jean-Philippe

2024

Volltextzugriff (PDF)

Circulating Tumor Cell Clusters: United We Stand Divided We Fall

International journal of molecular sciences, 2020-04, Vol.21 (7), p.2653

2020

Volltextzugriff (PDF)

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity

Leukemia, 2021-06, Vol.35 (6), p.1696-1709

2021

Volltextzugriff (PDF)

MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories

Human pathology, 2021-08, Vol.114, p.99-109

2021

Volltextzugriff (PDF)

Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing

Journal of investigative dermatology, 2017-09, Vol.137 (9), p.1984-1994

2017

Volltextzugriff (PDF)

High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type

JAMA dermatology (Chicago, Ill.), 2014-11, Vol.150 (11), p.1173

2014

Volltextzugriff (PDF)

Diagnosis and treatment of lymphomas in the era of epigenetics

Blood reviews, 2021-07, Vol.48, p.100782-100782, Article 100782

2021

Volltextzugriff (PDF)

Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing

PloS one, 2013-08, Vol.8 (8), p.e70826-e70826

2013

Volltextzugriff (PDF)

Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas

Molecular oncology, 2022-05, Vol.16 (9), p.1931-1946

2022

Volltextzugriff (PDF)

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Journal of thoracic oncology, 2014-03, Vol.9 (3), p.295-306

2014

Volltextzugriff (PDF)

Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling

PloS one, 2022-04, Vol.17 (4), p.e0266978-e0266978

2022

Volltextzugriff (PDF)

PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

The American journal of surgical pathology, 2018-03, Vol.42 (3), p.326-334

2018

Volltextzugriff (PDF)

Primary cutaneous large B‐cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases

Histopathology, 2019-06, Vol.74 (7), p.1067-1080

2019

Volltextzugriff (PDF)

MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

Journal of investigative dermatology, 2012-08, Vol.132 (8), p.2118-2120

2012

Volltextzugriff (PDF)

Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas

Cancers, 2021-08, Vol.13 (17), p.4256

2021

Volltextzugriff (PDF)

Reliable blood cancer cells' telomere length evaluation by qPCR

Cancer medicine (Malden, MA), 2020-05, Vol.9 (9), p.3153-3162

2020

Volltextzugriff (PDF)

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

The European respiratory journal, 2017-08, Vol.50 (2), p.1700514-1700514

2017

Volltextzugriff (PDF)

TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma

PloS one, 2017-03, Vol.12 (3), p.e0173171-e0173171

2017

Volltextzugriff (PDF)

Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA

Frontiers in cell and developmental biology, 2021-02, Vol.8, p.622048-622048

2021

Volltextzugriff (PDF)

Single-cell trajectories in Sézary syndrome

Blood, 2021-10, Vol.138 (16), p.1384-1386

2021

Volltextzugriff (PDF)

hMZF-2 , the Elusive Transcription Factor

Frontiers in genetics, 2020-12, Vol.11, p.581115-581115

2020

Volltextzugriff (PDF)

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells

Frontiers in oncology, 2021-10, Vol.11, p.775253-775253

2021

Volltextzugriff (PDF)

Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas

Genes, 2022-03, Vol.13 (3), p.539

2022

Volltextzugriff (PDF)

C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma

Cancers, 2021-01, Vol.13 (2), p.270

2021

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Life Sciences & Biomedicine
(128)
Humans
(114)
Female
(57)
Pathology
(54)
Male
(52)
Middle Aged
(52)
Aged
(43)
Mutation
(34)
Biological And Medical Sciences
(33)
Life Sciences
(33)
Aged, 80 And Over
(32)
Adult
(31)
Medical Sciences
(31)
Skin Neoplasms - Genetics
(31)
Cancer
(27)
Dermatology
(27)
Skin Neoplasms - Pathology
(27)
Oncology
(25)
Hematologic And Hematopoietic Diseases
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Staphylococcus aureus and Sézary syndrome

Circulating Tumor Cell Clusters: United We Stand Divided We Fall

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity

MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories

Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing

High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type

Diagnosis and treatment of lymphomas in the era of epigenetics

Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing

Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling

PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

Primary cutaneous large B‐cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases

MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas

Reliable blood cancer cells' telomere length evaluation by qPCR

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma

Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA

Single-cell trajectories in Sézary syndrome

hMZF-2 , the Elusive Transcription Factor

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells

Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas

C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma

Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma

Suchergebnisse filtern